ORLADEYO 150 mg, capsules 28 capsules
Active ingredients: BÉROTRALSTAT, DICHLORHYDRATE DE BÉROTRALSTAT
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule28 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ORLADEYO 150 mg, gélules
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- 4 plaquettes ACLAR RX) polytrifluorochloroéthylène PVC aluminium de 7 gélules
- Marketing authorisation holder
- BIOCRYST IRELAND LIMITED (IRLANDE)
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 5 Jul 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66859849CIP73022738CIP133400930227381Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BÉROTRALSTATgélule | 150 mg · une gélule | FT |
| DICHLORHYDRATE DE BÉROTRALSTATgélule | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.